NDC 72162-1939-01 - Hyoscyamine Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-1939
- Requested NDC
- 72162-1939-01
- Package NDCs from labels
- 72162-1939-1, 72162-1939-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2023-08-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hyoscyamine Sulfate - Bryant Ranch Prepack | Bryant Ranch Prepack | 2023-08-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-1939-1 | Hyoscyamine Sulfate | 100 in 1 BOTTLE | TABLET | 100 | 100 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-1939 | HYOSCYAMINE SULFATE TABLET [BRYANT RANCH PREPACK] | 100 | Current NDC, 1 package rows | 20230901_7258faac-4e08-469b-950c-abe5a5f94445.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-1939-1 | EA - Each | 72162-1939 | 152bcd61-3657-4ff7-8039-bfe8d6401cc5 | 1 | 2024-01-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Granulation Technology, Inc. | d81bf93e-e73f-4b12-980b-33a5bf453142 | 2026-04-10 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate Sublingual | HYOSCYAMINE SULFATE SUBLINGUAL | Direct_Rx | 4cc2a7a4-b549-b92a-e063-6294a90a51e3 | 2026-03-11 | Warnings, Adverse reactions | F2R8V82B84 |
| UROGESIC BLUE | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | EDWARDS PHARMACEUTICALS, INC. | f650dd78-615c-42d3-9b2d-3a989039d80c | 2026-03-05 | Warnings, Adverse reactions | F2R8V82B84 |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Northwind Health Company, LLC | da704abd-4e60-f32e-e053-2a95a90a2830 | 2026-01-01 | Warnings, Adverse reactions | 1047905 F2R8V82B84 |
| Hyoscyamine Sulfate TAB | HYOSCYAMINE SULFATE | Northwind Health Company, LLC | f75765ce-262c-e832-e053-6394a90a6066 | 2026-01-01 | Warnings, Adverse reactions | 1047905 F2R8V82B84 |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| HYOSCYAMINE SULFATE | HYOSCYAMINE SULFATE | BPI Labs LLC | 6c0a1fef-c634-4ecf-9850-d188e6496b90 | 2025-12-26 | Warnings, Adverse reactions | F2R8V82B84 |
| Uretron D/S | METHENAMINE, SODIUM PHOSPHATE MONOBASIC, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals | ea74f1aa-2b4d-4ccf-e053-2995a90abab5 | 2025-12-18 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate TAB | HYOSCYAMINE SULFATE | QPharma, Inc. | fc7566e6-c043-fcd4-e053-6294a90a77e5 | 2025-12-16 | Warnings, Adverse reactions | 1047905 F2R8V82B84 |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 8f8f53e3-fe31-e7b5-e053-2995a90a710d | 2025-11-14 | Warnings | 3OWL53L36A |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 9984a510-30be-4013-e053-2995a90a841e | 2025-11-14 | Warnings | 3OWL53L36A |
| Mannitol | MANNITOL | ProPharma Distribution | 430669d7-9ad1-9a04-e063-6394a90ababb | 2025-11-07 | Warnings, Adverse reactions | 3OWL53L36A |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 3OWL53L36A |
| Uro-MP | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE | Method Pharmaceuticals, LLC | 1e1b0dee-1a3b-4846-a212-c9febb3fc17d | 2025-10-29 | Warnings, Adverse reactions | F2R8V82B84 |
| Mannitol | MANNITOL | ICU Medical Inc. | ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 | 2025-10-24 | Warnings, Adverse reactions | 3OWL53L36A |
| Hyoscyamine Sulfate ODT | HYOSCYAMINE SULFATE | Acella Pharmaceuticals, LLC | eef6babc-241f-40b6-b8c8-daa92bbd0a25 | 2025-10-21 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate | HYOSCYAMINE SULFATE | Laser Pharmaceuticals, LLC | b12f856f-7157-4aee-bf73-1fdcb4834ffc | 2025-10-17 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate SL | HYOSCYAMINE SULFATE | Acella Pharmaceuticals, LLC | 8aab1dce-0699-4866-8707-33b4e2177bdd | 2025-10-02 | Warnings, Adverse reactions | F2R8V82B84 |
| Hyoscyamine Sulfate TAB | HYOSCYAMINE SULFATE | Acella Pharmaceuticals, LLC | 49fe1783-ab0c-4adb-869b-384121cf7f05 | 2025-10-02 | Warnings, Adverse reactions | 1047905 F2R8V82B84 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.